Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-07

FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Supplemental Application (Mayne Pharma Commercial LLC)

View source ↗

Summary

FDA approved a supplemental application for methamphetamine hydrochloride (Mayne Pharma Commercial LLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHAMPHETAMINE HYDROCHLORIDE (Methamphetamine hydrochloride)

Snippet

SUPPL AP for METHAMPHETAMINE HYDROCHLORIDE (METHAMPHETAMINE HYDROCHLORIDE)